Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Zacks.com on MSN4d
GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares Rise
Shares of Novo Nordisk and Eli Lilly gain following study results that show GLP-1 drugs cut the risk of heart and kidney ...
verywellhealth3d
What's Next for Alzheimer's Treatment? Some Scientists Are Betting on GLP-1 Drugs
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...
Pharm Exec5d
Novel GLP-1 Receptor Agonist Demonstrates Promising Results Treating Patients with Obesity
Data from a Phase Ia single ascending dose study found that ASC30 demonstrated dose-proportional pharmacokinetics, a ...
PharmiWeb3d
Glp-1 Analogues Market Share to Exceed USD 606.3 Billion by 2034
Glp-1 Analogues Market OverviewThe Glp analogues market size is expected to be worth USD 606.3 billion by 2034.The target market was valued at USD 45.3 billion in 2024.The market is projected to grow ...
Moneyweb3d
The appetite for GLP-1 drugs grows
The nature of the beast is yes, these drugs come off patent; the demand is there and someone could produce it more cheaply’, ...